Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene‐dose effect and intrasubject variability

OQP Yin, B Tomlinson, AHL Chow… - The Journal of …, 2004 - Wiley Online Library
The objective of this study was to determine the reliability of omeprazole as a marker for
CYP2C19 activity in Chinese subjects. In 27 healthy male Chinese subjects, the CYP2C19 …

Determination of CYP2C19 phenotype in black Americans with omeprazole: correlation with genotype

JS Marinac, JD Balian, JW Foxworth… - Clinical …, 1996 - Wiley Online Library
Background Our objective was to study omeprazole as a single‐dose oral probe in the
determination of CYP2C19 phenotype in black subjects and to determine the correlation …

CYP2C19 genotype and phenotype determined by omeprazole in a Korean population

HK Roh, ML Dahl, G Tybring, H Yamada… - Pharmacogenetics …, 1996 - journals.lww.com
Omeprazole (20 mg orally) was given to 103 healthy Korean subjects and blood was taken 3
h alter administration. The plasma concentration ratio of omeprazole and …

Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy

M Kimura, I Ieiri, Y Wada, K Mamiya… - British journal of …, 1999 - Wiley Online Library
Aims To evaluate the reliability of the omeprazole hydroxylation index as a marker for
polymorphic CYP2C19 activity in a Japanese population of healthy young subjects (n= 78) …

Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

RM Baldwin, S Ohlsson, RS Pedersen… - British journal of …, 2008 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• The only existing study of CYP2C19*
17‐associated alterations in drug pharmacokinetics was retrospective and compared probe …

CYP2C19 genotype and omeprazole hydroxylation phenotype in Chinese Li population

JH Wang, PQ Li, QY Fu, QX Li… - Clinical and Experimental …, 2007 - Wiley Online Library
SUMMARY 1 CYP2C19 is a polymorphism of cytochrome P450, which is responsible for the
metabolism of many drugs. The genetic polymorphism shows interethnic variation and it has …

Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid–liquid …

HM González, EM Romero, T de J Chavez… - … of Chromatography B, 2002 - Elsevier
We present a new simple and reliable HPLC method for measuring omeprazole and its two
main metabolites in plasma. This can be used for studying CYP2C19 and CYP3A4 genetic …

CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin

Q Zhou, I Yamamoto, T Fukuda, M Ohno… - European journal of …, 1999 - Springer
Objectives: Omeprazole is metabolized mainly by CYP2C19 which has two major mutations
(CYP2C19* 2 in exon5 and CYP2C19* 3 in exon4) associated with the poor metabolizer …

Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people

X Hu, J Xu, Y Hu, Q Mei, X Xu - Journal of clinical pharmacy …, 2007 - Wiley Online Library
Background: To investigate whether the pharmacodynamics and pharmacokinetics of
omeprazole (OPZ) are dependent of the CYP2C19 genotype status in Chinese people …

CYP2C19‐and CYP3A4‐dependent omeprazole metabolism in West Mexicans

HM Gonzalez, EMT Romero… - The Journal of …, 2003 - Wiley Online Library
Omeprazole has been used as a drug probe for CYP2C19, but no systematic data are
available for Mexican populations. The aim of this study was to evaluate the phenotype …